Most Accessed Articles

Recent Advances in Cancer Therapy: An Overview

, 2010; 16(1): 3-10.

A. Urruticoechea, R. Alemany, J. Balart, A. Villanueva, F. Vinals and G. Capella


DOI: 10.2174/138161210789941847


Antiepileptic Drugs in Clinical Development: Differentiate or Die?

, 2017; 23(37): 5593-5605.

Gaetano Zaccara* and D. Schmidt


DOI: 10.2174/1381612823666170809100524


Quorum Sensing Inhibitors as Anti-Biofilm Agents

, 2015; 21(1): 5-11.

Gilles Brackman and Tom Coenye


DOI: 10.2174/1381612820666140905114627


Aminoglycoside-Induced Ototoxicity

, 2007; 13(1): 119-126.

Erol Selimoglu


DOI: 10.2174/138161207779313731


Immune Antibody Libraries: Manipulating The Diverse Immune Repertoire for Antibody Discovery

, 2016; 22(43): 6480-6489.

Theam Soon Lim and Soo Khim Chan


DOI: 10.2174/1381612822666160923111924


Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion Injury

, 2017; 23(26): 3884-3898.

Yuanyuan Cheng and Jianhui Rong*


DOI: 10.2174/1381612823666170413122439


Tissue Engineered Skin and Wound Healing: Current Strategies and Future Directions

, 2017; 23(24): 3455-3482.

Nandana Bhardwaj*, Dimple Chouhan and Biman B. Mandal


DOI: 10.2174/1381612823666170526094606


The Therapeutic Target Hsp90 and Cancer Hallmarks

, 2013; 19(3): 347-365.

Yoshihiko Miyata, Hitoshi Nakamoto and Len Neckers


DOI: 10.2174/1381612811306030347


Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer

, 2017; 23(25): 3699-3712.

Jens Oellgaard*, Signe Abitz Winther, Tobias Schmidt Hansen, Peter Rossing and Bernt Johan von Scholten


DOI: 10.2174/1381612823666170622095324


Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science